Dickson Samuel P, Hendrix Suzanne B, Brown Bruce L, Ridge Perry G, Nicodemus-Johnson Jessie, Hardy Marci L, McKeany Allison M, Booth Steven B, Fortna Ryan R, Kauwe John S K
Pentara Corporation Salt Lake City Utah USA.
Department of Psychology Brigham Young University Provo Utah USA.
Alzheimers Dement (N Y). 2021 Sep 30;7(1):e12211. doi: 10.1002/trc2.12211. eCollection 2021.
Recent clinical trials are considering inclusion of more than just apolipoprotein E () ε4 genotype as a way of reducing variability in analysis of outcomes.
Case-control data were used to compare the capacity of age, sex, and 58 Alzheimer's disease (AD)-associated single nucleotide polymorphisms (SNPs) to predict AD status using several statistical models. Model performance was assessed with Brier scores and tenfold cross-validation. Genotype and sex × age estimates from the best performing model were combined with age and intercept estimates from the general population to develop a personalized genetic risk score, termed age, and sex-adjusted GenoRisk.
The elastic net model that included age, age x sex interaction, allelic terms, and 29 additional SNPs performed the best. This model explained an additional 19% of the heritable risk compared to genotype alone and achieved an area under the curve of 0.747.
GenoRisk could improve the risk assessment of individuals identified for prevention studies.
近期的临床试验正在考虑纳入除载脂蛋白E()ε4基因型之外的更多因素,以此减少结果分析中的变异性。
利用病例对照数据,通过几种统计模型比较年龄、性别和58种阿尔茨海默病(AD)相关单核苷酸多态性(SNP)预测AD状态的能力。使用布里尔评分和十折交叉验证评估模型性能。将表现最佳模型的基因型和性别×年龄估计值与来自一般人群的年龄和截距估计值相结合,以制定个性化遗传风险评分,称为年龄和性别调整后的基因风险(GenoRisk)。
包含年龄、年龄×性别交互作用、等位基因项和另外29个SNP的弹性网络模型表现最佳。与仅使用基因型相比,该模型解释了额外19%的遗传风险,曲线下面积达到0.747。
基因风险(GenoRisk)可以改善为预防研究而确定的个体的风险评估。